公开(公告)号：US20210107922A1

公开(公告)日：2021-04-15

申请号：US17052978

申请日：2019-05-06

Applicant: UCB Biopharma SRL

Inventor： Hugues Chanteux ,  Yannick Quesnel ,  Claude Delatour ,  Laurent Provins

IPC: C07D513/04

Abstract: The present invention relates to 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.

公开(公告)号：US20240059665A1

公开(公告)日：2024-02-22

申请号：US18267331

申请日：2021-12-16

Applicant: UCB Biopharma SRL

Inventor： Claude Delatour

IPC: C07D401/06

CPC classification number: C07D401/06

Abstract: The present invention relates to compound according to formula (I) which is a positive allosteric modulator of D1 and accordingly of benefit as pharmaceutical agent for the treatment of diseases in which D1 receptors play a role.

公开(公告)号：US11286266B2

公开(公告)日：2022-03-29

申请号：US17052978

申请日：2019-05-06

Applicant: UCB Biopharma SRL

Inventor： Hugues Chanteux ,  Yannick Quesnel ,  Claude Delatour ,  Laurent Provins

IPC: C07D513/04

Abstract: The present invention relates to 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.